Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 2
2008 2
2010 3
2011 3
2012 2
2013 2
2014 4
2015 5
2016 4
2017 1
2018 6
2019 7
2020 10
2021 14
2022 7
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFRWT and EGFRT790M: design, synthesis, ADMET and molecular docking.
Aljohani AKB, El-Adl K, Almohaywi B, Alatawi OM, Alsulaimany M, El-Morsy A, Almadani SA, Alharbi HY, Aljohani MS, Abdulhaleem M FA, Osman HEM, Mohamady S. Aljohani AKB, et al. Among authors: el morsy a. RSC Adv. 2024 Mar 6;14(12):7964-7980. doi: 10.1039/d4ra00502c. eCollection 2024 Mar 6. RSC Adv. 2024. PMID: 38454937 Free PMC article.
Design, synthesis, docking, ADMET and anticancer evaluations of N-alkyl substituted iodoquinazoline derivatives as dual VEGFR-2 and EGFR inhibitors.
Alsulaimany M, El-Adl K, Aljohani AKB, Alharbi HY, Alatawi OM, Aljohani MS, El-Morsy A, Almadani SA, Alsimaree AA, Salama SA, Keshek DE, Mohamed AA. Alsulaimany M, et al. Among authors: el morsy a. RSC Adv. 2023 Dec 13;13(51):36301-36321. doi: 10.1039/d3ra07700d. eCollection 2023 Dec 8. RSC Adv. 2023. PMID: 38093733 Free PMC article.
Five and six membered heterocyclic rings endowed with azobenzene as dual EGFRT790M and VEGFR-2 inhibitors: design, synthesis, in silico ADMET profile, molecular docking, dynamic simulation and anticancer evaluations.
Anwer KE, El-Hddad SSA, Abd El-Sattar NEA, El-Morsy A, Khedr F, Mohamady S, Keshek DE, Salama SA, El-Adl K, Hanafy NS. Anwer KE, et al. Among authors: el morsy a. RSC Adv. 2023 Dec 4;13(50):35321-35338. doi: 10.1039/d3ra06614b. eCollection 2023 Nov 30. RSC Adv. 2023. PMID: 38053688 Free PMC article.
Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies.
Aljohani AKB, El Zaloa WAZ, Alswah M, Seleem MA, Elsebaei MM, Bayoumi AH, El-Morsy AM, Almaghrabi M, Awaji AA, Hammad A, Alsulaimany M, Ahmed HEA. Aljohani AKB, et al. Among authors: el morsy am. Int J Mol Sci. 2023 Oct 9;24(19):15026. doi: 10.3390/ijms241915026. Int J Mol Sci. 2023. PMID: 37834474 Free PMC article.
Cost-effectiveness of HARNESS-MRI protocol in focal drug-resistant epilepsy in a limited-resources country: An Egyptian study.
Kishk NA, Shamloul R, Moawad MK, Hamdi H, Morsy AA, Baghdadi M, Rizkallah M, Nawito A, Mohammad ME, Magdy R, Alsayyad E, Othman AS, Fouad AM, Rizk H. Kishk NA, et al. Among authors: morsy aa. Clin Neurol Neurosurg. 2023 Oct;233:107946. doi: 10.1016/j.clineuro.2023.107946. Epub 2023 Aug 18. Clin Neurol Neurosurg. 2023. PMID: 37639829
84 results